First published · Last updated
Synergistic effects and molecular mechanisms of pirfenidone combined with EGFR-TKIs in non-small cell lung cancer
Journal article reporting on combined use of pirfenidone and EGFR-TKIs in non-small cell lung cancer. The supplied source data includes only the title, publisher, and publication metadata without study details.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 2/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Positivity
- 5/10
- Urgency
- 2/10
Why it matters
The article presents research findings about a drug combination relevant to non-small cell lung cancer.

